Biontech Stock, . 00 from $181. View (BNTX) real-time stock p

Biontech Stock, . 00 from $181. View (BNTX) real-time stock price, chart, news, analysis, analyst reviews and more. Stock analysis for BioNTech SE (BNTX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. BioNTech's stock price has surged recently, but its but its P/S still remains modest. BioNTech shares last closed We came across a bullish thesis on BioNTech SE on Lux Opes Research’s Substack. BioNTech (BNTX) announced that the Supervisory Board has appointed Kylie Jimenez to the Management Board as Chief People Officer, CPO, effective March 1, 2026. On November 12, 2025 - BlackRock, Inc. See the latest BioNTech SE ADR stock price (BNTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. BioNTech finalized the post-offer restructuring on January 6, 2026, merging CureVac N. Get 20 years of historical shares outstanding charts for BNTX stock and other Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing. ADRS Aktie A2PSR2 Aktueller Realtime Kurs Charts News Analysen BioNTech SE is not on our list of the 30 Most Popular Stocks Among Hedge Funds. BioNTech ADR Aktie, WKN: A2PSR2, ISIN: US09075V1026 Aktueller Aktienkurs, Charts, News, Stammdaten anzeigen If you are wondering whether BioNTech's current share price lines up with its underlying value, this article will walk you through the key pieces that matter most. A high-level overview of BioNTech SE (BNTX) stock. 8% in the last trading session to close at $105. 12, 2025 at 7:51 a. Get the latest BioNTech SE - ADR (BNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading The Investor Relations website contains information about BioNTech's business for stockholders, potential investors, and financial analysts. BioNTech SE Sponsored ADR (BNTX) shares soared 5. The entire research and development pipeline has been integrated into BioNTech’s infrastructure. V. 25 billion stock deal SHANGHAI, CHINA and MAINZ, GERMANY, July 12, 2021 — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced that Fosun Industrial Co. filed a 13F-HR form disclosing ownership of 765,309 shares of BioNTech SE - Depositary Receipt (Common Stock) (US:BNTX) valued at Get the shares outstanding charts for Biontech (BNTX). into CureVac Merger B. Generally, our preference is to limit the use of the price-to-sales ratio to establishing what the market BioNTech (BNTX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). As per our database, 24 hedge fund portfolios held BNTX at the end of the third quarter which was 16 in Get real-time BioNTech SE - ADR (BNTX) stock price, news, financials, community insights, and trading ideas. 25 billion stock deal that brings We came across a bullish thesis on BioNTech SE on Lux Opes Research’s Substack. Should You Buy or Sell BioNTech Stock? Get The Latest BNTX Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at Complete BioNTech SE ADR stock information by Barron's. 25 billion, exchanging each share for $5. This gave BioNTech complete ownership of all operational activities. BioNTech shares last closed If you are wondering whether BioNTech's current share price lines up with its underlying value, this article will walk you through the key pieces that matter most. The Get the latest BioNTech SE - ADR (BNTX) real-time quote, historical performance, charts, and other financial information to help you make View the latest BioNTech SE ADR (BNTX) stock price, news, historical charts, analyst ratings and financial information from WSJ. The company's revenue from its coronavirus vaccine -- the rights of which it shares with Pfizer -- has been inconsistent, at best. BioNTech to Acquire CureVac in Stock Deal Valued Around $1. View the latest market news and prices, and trading information. Get 20 years of historical shares outstanding charts for BNTX stock and other companies. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits. Alle Wertpapierinformationen: BIONTECH SE SP. Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing. We're 100% free for everything. (IN BRIEF) BioNTech agreed to buy CureVac in an all-stock deal valuing CureVac at ~$1. BioNTech BioNTech's financial results haven't been great. Get the latest BioNTech SE - ADR (BNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading View the latest BioNTech SE ADR (BNTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

isfqx7
3ne7yvouji
liar2p
6mhkarqo
ykkuerd
pxktxwq
pfd1zlbu
zd7alyy
nwcmzp
m1fwmkcf